Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flepp

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1985
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urineB Joos, B Ledergerber, M Flepp, et al.
HIV Clinical Trials|June 27, 2006
Tenofovir-containing nucleoside/nucleotide-only antiretroviral maintenance therapy: decision making and virological outcomeManuela Buehlmann, Jean-Philippe Chave, Markus Flepp, et al.
International Journal of Antimicrobial Agents|December 19, 2000
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failureJ Schüpbach, Z Tomasik, D Nadal, et al.
AIDS Care|November 25, 2000
A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, SwitzerlandB Somaini, J Wang, M Perozo, et al.
Schweizerische Medizinische Wochenschrift|November 12, 1988
[Malignant lymphomas in HIV-infected patients]H Adam, M Flepp, G Schüler, et al.
Pharmacogenetics and Genomics|September 22, 2007
Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7Margalida Rotger, Maria Saumoy, Kunlin Zhang, et al.
AIDS (London, England)|May 1, 1996
Reasons for failure of prevention of Toxoplasma encephalitis. Swiss HIV Cohort StudyC Van Delden, V Gabriel, P Sudre, et al.
Praxis|October 31, 2013
[Hoarsness after a trip to the United States of America]Aleksandra Nobile, Reto A Schüpbach, Markus Flepp, et al.
The Journal of Infectious Diseases|April 6, 2000
Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurementB Ledergerber, M Flepp, J Böni, et al.
AIDS (London, England)|September 15, 2004
Gynecomastia and potent antiretroviral therapyChristoph Strub, Gilbert R Kaufmann, Markus Flepp, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|March 1, 1985
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urineB Joos, B Ledergerber, M Flepp, et al.
HIV Clinical Trials|June 27, 2006
Tenofovir-containing nucleoside/nucleotide-only antiretroviral maintenance therapy: decision making and virological outcomeManuela Buehlmann, Jean-Philippe Chave, Markus Flepp, et al.
International Journal of Antimicrobial Agents|December 19, 2000
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failureJ Schüpbach, Z Tomasik, D Nadal, et al.
AIDS Care|November 25, 2000
A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, SwitzerlandB Somaini, J Wang, M Perozo, et al.
Schweizerische Medizinische Wochenschrift|November 12, 1988
[Malignant lymphomas in HIV-infected patients]H Adam, M Flepp, G Schüler, et al.
Pharmacogenetics and Genomics|September 22, 2007
Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7Margalida Rotger, Maria Saumoy, Kunlin Zhang, et al.
AIDS (London, England)|May 1, 1996
Reasons for failure of prevention of Toxoplasma encephalitis. Swiss HIV Cohort StudyC Van Delden, V Gabriel, P Sudre, et al.
Praxis|October 31, 2013
[Hoarsness after a trip to the United States of America]Aleksandra Nobile, Reto A Schüpbach, Markus Flepp, et al.
The Journal of Infectious Diseases|April 6, 2000
Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurementB Ledergerber, M Flepp, J Böni, et al.
AIDS (London, England)|September 15, 2004
Gynecomastia and potent antiretroviral therapyChristoph Strub, Gilbert R Kaufmann, Markus Flepp, et al.
Pageof 12